pubmed-article:18998045 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18998045 | lifeskim:mentions | umls-concept:C0935640 | lld:lifeskim |
pubmed-article:18998045 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:18998045 | lifeskim:mentions | umls-concept:C1135183 | lld:lifeskim |
pubmed-article:18998045 | lifeskim:mentions | umls-concept:C0013878 | lld:lifeskim |
pubmed-article:18998045 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:18998045 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:18998045 | pubmed:dateCreated | 2009-1-6 | lld:pubmed |
pubmed-article:18998045 | pubmed:abstractText | The capsid protein of PCV2 was expressed by using a recombinant baculovirus with insect Tn5 cells. A large amount of 28-kDa protein was released into the culture medium and self-assembled into PCV2-like particles (PCV2-LPs) with a buoyant density of 1.365 g/cm(3) and a diameter of 20 nm. PCV2-LPs were efficiently expressed, yielding 1 mg of purified particles per 10(7) Tn5 cells. The PCV2-LPs have antigenicity similar to that of authentic PCV2 particles, allowing us to develop a method for sensitively detecting PCV2-specific IgG antibodies. In addition, the PCV2-LPs appeared to be the most promising PCV2 vaccine candidate, by virtue of their potent immunogenicity. | lld:pubmed |
pubmed-article:18998045 | pubmed:language | eng | lld:pubmed |
pubmed-article:18998045 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18998045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18998045 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18998045 | pubmed:issn | 1432-8798 | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:TakedaNaokazu... | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:MiyamuraTatsu... | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:LiTian-ChengT... | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:KataokaMichiy... | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:WakitaTakajiT | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:SuzukiTakakoT | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:TsunemitsuHir... | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:LiuLan-JunLJ | lld:pubmed |
pubmed-article:18998045 | pubmed:author | pubmed-author:NgataNoriyoN | lld:pubmed |
pubmed-article:18998045 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18998045 | pubmed:volume | 153 | lld:pubmed |
pubmed-article:18998045 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18998045 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18998045 | pubmed:pagination | 2291-5 | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:meshHeading | pubmed-meshheading:18998045... | lld:pubmed |
pubmed-article:18998045 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18998045 | pubmed:articleTitle | Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus. | lld:pubmed |
pubmed-article:18998045 | pubmed:affiliation | Department of Virology II, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashi-murayama, Tokyo, 208-0011, Japan. | lld:pubmed |
pubmed-article:18998045 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18998045 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |